Literature DB >> 1727888

Disseminated Nocardia transvalensis infection: an unusual opportunistic pathogen in severely immunocompromised patients.

M M McNeil1, J M Brown, C H Magruder, K T Shearlock, R A Saul, D P Allred, L Ajello.   

Abstract

Nocardia infections are infrequently recognized in humans. Nocardia species may cause severe life-threatening infections among immunocompromised patients and have been reported to cause actinomycotic mycetomas, primarily in tropical areas. Two severely immunocompromised patients had disseminated N. transvalensis infections. One had underlying X-linked variant chronic granulomatous disease and died of disseminated N. transvalensis infection, which was diagnosed only at postmortem examination. The second patient developed N. transvalensis pneumonia within 3 months of undergoing renal transplantation and died of disseminated mixed Pseudallescheria boydii and N. transvalensis infections. Thus, N. transvalensis may cause invasive and potentially fatal pulmonary and disseminated infections. Accordingly, clinical microbiology laboratories should become proficient in identifying this uncommon aerobic actinomycete.

Entities:  

Mesh:

Year:  1992        PMID: 1727888     DOI: 10.1093/infdis/165.1.175

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis.

Authors:  R W Wilson; V A Steingrube; B A Brown; Z Blacklock; K C Jost; A McNabb; W D Colby; J R Biehle; J L Gibson; R J Wallace
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 2.  Update and actual trends on bacterial infections following liver transplantation.

Authors:  Jose Luis del Pozo
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

Review 3.  Disseminated Nocardia transvalensis infection resembling pulmonary infarction in a liver transplant recipient.

Authors:  M Weinberger; A Eid; L Schreiber; M Shapiro; Y Ilan; E Libson; T Sacks; R Tur-Kaspa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

Review 4.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  Nocardia thyroiditis: unusual location of infection.

Authors:  C Carriere; H Marchandin; J M Andrieu; A Vandome; C Perez
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates.

Authors:  R W Wilson; V A Steingrube; B A Brown; R J Wallace
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 7.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex.

Authors:  V A Steingrube; B A Brown; J L Gibson; R W Wilson; J Brown; Z Blacklock; K Jost; S Locke; R F Ulrich; R J Wallace
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 9.  Nocardia species: host-parasite relationships.

Authors:  B L Beaman; L Beaman
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 10.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.